Discover

TXG
10x Genomics, Inc.
80.65
2 x 60.29
2 x 102.14
bid
ask
+
3.37
4.36%
2 @ 07:41 PM
81.05 +0.40 (0.50%)
Ytd394.48%
1y588.73%
79.16
day range
85.12
11.47
52 week range
97.74
Open79.16Prev Close77.28Low79.16High85.12Mkt Cap10.51B
Vol3.69MAvg Vol3.29MEPS-0.59P/EN/AForward P/E1051.91
Beta1.99Short Ratio6.17Inst. Own120.31%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0550-d Avg67.73200-d Avg36.091yr Est69.47
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-052026-09-0.26N/AN/AN/A
2026-08-062026-06-0.24-0.140.142.41%
2026-05-072026-03-0.29-0.10.1965.52%
2026-02-122025-12-0.19-0.130.0631.58%
2025-11-062025-09-0.07-0.22-0.15-214.29%
2025-08-072025-06-0.350.280.63180.00%
Upgrade / Downgrade
DateFirmActionFromTo
2026-10-07BarclaysUpgradeOverweightOverweight
2026-09-29Leerink PartnersUpgradeMarket PerformMarket Perform
2026-09-28Piper SandlerUpgradeNeutralNeutral
2026-09-28Argus ResearchUpgradeBuy
2026-09-09UBSUpgradeNeutralNeutral
2026-09-01RBC CapitalUpgradeSector Perform
Profile
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Insider Holder
DateNameRelationQuantityDescription
2026-08-23HINDSON BENJAMIN JPresident488.18KSale
2026-06-03KOSARAJU SRIDHARDirector68.28KStock Award(Grant)
2026-06-03MATEO ALAN V.Director85.88KStock Award(Grant)
2026-06-03POPOVITS KIMBERLY JDirector37.45KStock Award(Grant)
2026-09-21SAXONOV SERGE WILSONChief Executive Officer1.34MSale
2026-09-02STUELPNAGEL JOHN RDirector328.44KSale
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29FMR, LLC17.63M1.42B14.67%
2026-06-29Blackrock Inc.10.80M871.35M8.99%
2026-06-29ARK Investment Management, LLC10.00M806.75M8.32%
2026-06-29Vanguard Portfolio Management LLC6.98M563.14M5.81%
2026-06-29Quantinno Capital Management, LP5.47M441.13M4.55%
2026-06-29Vanguard Capital Management LLC5.08M409.91M4.23%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.53M284.59M2.94%
2026-08-30iShares Trust-iShares Russell 2000 ETF3.06M246.71M2.54%
2026-08-30ARK ETF Trust-ARK Genomic Revolution ETF3.04M244.92M2.53%
2026-08-30ARK ETF Trust-ARK Innovation ETF3.01M242.60M2.50%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.55M205.54M2.12%
2026-08-30Fidelity Select PORT.s-Select Medical Technology and Devices PORT.2.00M161.30M1.66%
Split
SplitDate
1 : 22006-07-17
2 : 12006-07-16